Key House lawmakers have come to a bipartisan agreement to move forward long-stalled legislation aimed at lowering drug prices. The agreement will allow the bills, aimed at increasing competition from cheaper generic drugs, to advance from the committee on a bipartisan vote expected later on Wednesday.